Michael Dunn
Neurology · Rochester, NYNPI 1780672592
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,312 of the $69,967 with a category attached, or 87.6%. 35 manufacturers reported payments, led by Sanofi at 57.2% of the total. Reporting peaked in 2019 at $69,773 and has fallen 100.0% since, to $26 in 2021. Among neurology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 413 payments — averaging $169.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$40K
- Biogen$16K
- Genentech USA, Inc.$7K
- Teva Pharmaceuticals USA, Inc.$3K
- Supernus Pharmaceuticals, Inc.$448
- Novartis$410
- plus $3K from 29 others
What the payments were for
- Consulting fees$2,2693%
- Speaking & faculty fees$61,31288%
- Travel & lodging$7851%
- Food & beverage$5,5148%
- Education$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 65 | $40,039 |
| Biogen | 33 | $16,065 |
| Genentech USA, Inc. | 21 | $6,829 |
| Teva Pharmaceuticals USA, Inc. | 25 | $3,258 |
| Supernus Pharmaceuticals, Inc. | 46 | $448 |
| Novartis | 29 | $410 |
| AbbVie(2 entities) | 24 | $274 |
| Lundbeck LLC | 16 | $250 |
| EMD Serono, Inc. | 15 | $222 |
| Mallinckrodt Enterprises LLC | 9 | $210 |
| Amgen | 8 | $185 |
| Jazz Pharmaceuticals Inc. | 11 | $178 |
| Acorda Therapeutics, Inc | 8 | $166 |
| Merz North America, Inc. | 7 | $159 |
| Lilly USA, LLC | 21 | $150 |
| Avanir Pharmaceuticals, Inc. | 8 | $139 |
| Sunovion Pharmaceuticals Inc. | 9 | $132 |
| Neurocrine Biosciences, Inc. | 7 | $121 |
| Grifols USA, LLC | 6 | $109 |
| CSL Behring | 5 | $93 |
| UCB, Inc. | 4 | $73 |
| Promius Pharma LLC | 4 | $58 |
| GE HealthCare | 4 | $49 |
| Zyla Life Sciences, Inc. | 4 | $48 |
| Livanova USA, Inc. | 3 | $48 |
| MDD US Operations, LLC | 3 | $44 |
| Upsher-smith Laboratories LLC | 3 | $41 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $35 |
| Tanabe Pharma America, Inc. | 1 | $22 |
| Bayer | 1 | $19 |
| Akcea Therapeutics, Inc. | 1 | $14 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$69,967 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.
Other neurology in Rochester
- Jacob DominikRochester$216K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.